Cartalax 50 mg × 1 Vial
Batch-tested · Switzerland
Peptide · Single vial

Cartalax 50 mg × 1 vial.

Cartalax is a short synthetic peptide bioregulator (Ala-Glu-Asp) developed in Russia.

Strength
50 mg / vial
Pack
1 vial
Format
Freeze-dried
Research area
Ageing

Have this box? Check it's genuine.

Type the six digits from the label.

Have this box? Check it's genuine.

For laboratory research use only. Not for human consumption.

Reference profile
Reference profile

What it is.

Cartalax is a short synthetic peptide bioregulator (Ala-Glu-Asp) developed in Russia. It is one of the Khavinson peptides and was designed around joint and connective tissue.

Key facts
  • Peptide bioregulator
  • Tripeptide
  • Ala-Glu-Asp

How it is used.

Cartalax is studied in bioregulator and ageing research. Studies look at cell renewal and gene expression in connective-tissue cells, mostly in cell and animal models.

Studied in
  • Peptide bioregulators
  • Connective tissue
  • Ageing research
Quality

Tested before it's boxed.

Every batch is made in-house in Switzerland and tested for identity, purity and sterility before it is packed.

How we test
Every batch is tested for
  • Identity LC-MS
  • Content HPLC-UV
  • Purity HPLC-UV
  • Sterility USP <71>
  • Endotoxins USP <85>
  • Particulates USP <788>